Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.21 EUR
Change Today -0.052 / -2.30%
Volume 0.0
EZB On Other Exchanges
Symbol
Exchange
New York
Munich
As of 2:56 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew P. Whiteley

Former Vice President of Business Development and Chief Operating Officer of Enzo Life Sciences Inc, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56$223,139
As of Fiscal Year 2014

Background*

Mr. Andrew P. Whiteley served as Vice President of Business Development at Enzo Biochem Inc. since May 2008. Mr. Whiteley served as Chief Operating Officer of Enzo Life Sciences Inc., a subsidiary of Enzo Biochem Inc. He served as Vice President of Bioinformatics and Vice President, Sequencing Business at Amersham Pharmacia Biotech, Inc., a provider of integrated drug discovery solutions since January 2000. He served as President of Vitra Bioscience, Inc. He served as ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

Former Chief Executive Officer, President and Director
2000-N/A
Former Chairman of the Board, Chief Executive Officer and President

Education*

Bachelor's Degree 1980
Nottingham University

Other Affiliations*

Annual Compensation*

Salary$190,867
Total Annual Compensation$190,867

Stock Options*

All Other Compensation$18,796
Unexercisable Options23,702
Total Number of Options23,702

Total Compensation*

Total Annual Cash Compensation$209,663
Total Short Term Compensation$190,867
Other Long Term Compensation$18,796
Total Calculated Compensation$223,139
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €2.21 EUR -0.052

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$767.9K
Rolland D. Carlson Ph.D.Chief Executive Officer and President
WaferGen Bio-systems, Inc.
--
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.